728x90

Ado-trastuzumab emtansine-TDM-1-Kadcyla

Ado-trastuzumab emtansine is a type of drug known as an antibody-drug conjugate. It is made up of the same monoclonal antibody found in trastuzumab attached to a chemo drug known as DM-1. In this type of drug, the antibody acts as a homing device, taking the chemo drug directly to the cancer cells.

This drug is injected into a vein (IV) every 3 weeks.

Side effects:

Common side effects include

  • fatigue
  • nausea
  • muscle and bone pain
  • low platelet counts
  • headache
  • constipation

 

Risk Factor

This drug can also cause more serious side effects, such as severe allergic reactions, liver damage, heart damage, and lung problems.

 

Pertuzumab-Perjeta

Lapatinib-Tykerb

Everolimus-Afinitor


Bone-directed therapy for breast cancer in men


 

Coping and support for male breast cancer

 


Related Topics

Benign breast conditions

General breast cancer terms

Types of breast cancer in men


References

http://www.cancer.org/cancer/breastcancerinmen/detailedguide/breast-cancer-in-men-what-is-breast-cancer-in-men

http://www.breastcancer.org/symptoms/types/male_bc

http://www.cancerresearchuk.org/about-cancer/type/rare-cancers/rare-cancers-name/breast-cancer-in-men

http://www.mayoclinic.org/diseases-conditions/male-breast-cancer/basics/coping-support/con-20025972


 

Oncologists, Breast Surgeons are the specialists who deal with the breast cancer

 

728x90